MAGELLAN HEALTH INC: 10-Q filed 2017-04-26

Name: MAGELLAN HEALTH INC: 10-Q filed 2017-04-26
Creator: MAGELLAN HEALTH INC
License: https://creativecommons.org/licenses/by/4.0/

What MAGELLAN HEALTH INC reported in its quarterly report filed 2017-04-26 (fiscal Q1 2017): 32 published measures, 65 facts as tagged in accession 0001558370-17-002920.

This filing

Form: 10-Q (quarterly report)
Filed: 2017-04-26
Fiscal period: fiscal Q1 2017
Accession: 0001558370-17-002920 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All MAGELLAN HEALTH INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2017-03-31	2,443,061,000	USD
At 2016-12-31	2,443,687,000	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2017-03-31	1,307,096,000	USD
At 2016-12-31	1,339,198,000	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2017-03-31	273,587,000	USD
At 2016-12-31	304,508,000	USD
At 2016-03-31	167,364,000	USD
At 2015-12-31	249,029,000	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	17,747,000	USD	90
2016-01-01 to 2016-03-31	13,237,000	USD	91

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	10,939,000	USD	90
2016-01-01 to 2016-03-31	15,611,000	USD	91

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	1,305,623,000	USD	90
2016-01-01 to 2016-03-31	1,117,022,000	USD	91

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2017-03-31	1,307,035,000	USD
At 2016-12-31	1,289,288,000	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	23,012,000	shares	90
2016-01-01 to 2016-03-31	23,631,000	shares	91

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	24,038,000	shares	90
2016-01-01 to 2016-03-31	24,511,000	shares	91

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	0.77	USD/shares	90
2016-01-01 to 2016-03-31	0.56	USD/shares	91

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	0.74	USD/shares	90
2016-01-01 to 2016-03-31	0.54	USD/shares	91

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	11,806,000	USD	90
2016-01-01 to 2016-03-31	12,013,000	USD	91

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2017-03-31	166,536,000	USD
At 2016-12-31	172,524,000	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	10,140,000	USD	90
2016-01-01 to 2016-03-31	8,887,000	USD	91

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2017-03-31	1,329,329,000	USD
At 2016-12-31	1,319,267,000	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	4,148,000	USD	90
2016-01-01 to 2016-03-31	1,748,000	USD	91

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2017-03-31	1,063,408,000	USD
At 2016-12-31	1,092,850,000	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2017-03-31	82,385,000	USD
At 2016-12-31	95,635,000	USD

Goodwill carrying amount

Recognized goodwill remaining after accumulated impairment. It arises from business combinations and does not measure the current value of the company’s brand.

Period	Value	Unit	Days
At 2017-03-31	742,775,000	USD
At 2016-12-31	742,054,000	USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

Period	Value	Unit	Days
At 2017-03-31	634,102,000	USD
At 2016-12-31	606,764,000	USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

Period	Value	Unit	Days
2016-01-01 to 2016-03-31	7,992,000	USD	91

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

Period	Value	Unit	Days
At 2017-03-31	62,374,000	USD
At 2016-12-31	58,995,000	USD

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit	Days
At 2017-03-31	1,131,473,000	USD
At 2016-12-31	1,099,719,000	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2017-03-31	177,054,000	USD
At 2016-12-31	186,232,000	USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

Period	Value	Unit	Days
At 2017-03-31	15,709,000	USD
At 2016-12-31	12,725,000	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2017-03-31	165,632,000	USD
At 2016-12-31	202,176,000	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	17,469,000	USD	90
2016-01-01 to 2016-03-31	13,391,000	USD	91

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	17,726,000	USD	90
2016-01-01 to 2016-03-31	13,475,000	USD	91

Depreciation, depletion and amortization

Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	26,976,000	USD	90
2016-01-01 to 2016-03-31	25,007,000	USD	91

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	-1,010,000	USD	90
2016-01-01 to 2016-03-31	-538,000	USD	91

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	27,699,000	USD	90
2016-01-01 to 2016-03-31	13,538,000	USD	91

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

Period	Value	Unit	Days
2017-01-01 to 2017-03-31	3,379,000	USD	90
2016-01-01 to 2016-03-31	5,121,000	USD	91

Inspect the source

Entity: MAGELLAN HEALTH INC / CIK 0000019411
Captured: 2026-09-22 19:27 UTC
SEC response SHA-256: 51abf13b428b7bf61a9743ee14a8ed424ab34b20dccd53e1c906533cd9ec8c4e

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0000019411.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))